Clinical Trials Browser

Phase 2 × Melanoma × Classical hematology × Clear all

NCT06508827 2025-07-09

Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

Phase 2 Withdrawn

Classical hematologyDermatologic

Anemia, Melanoma, Anemia, Iron-Deficiency